Description
The VA Enterprise Procurement Office will issue an unrestricted RFP (36E79726R0037) for the supply of Prednisolone Acetate 1% ophthalmic suspension to multiple federal health programs (VA, DoD/Tricare, BOP, IHS, FHCC). The contract will be a single-award, firm‑fixed‑price agreement for one year with four optional one‑year extensions. Offerors must provide the drug in three bottle sizes (5 ml, 10 ml, 15 ml) with specific labeling requirements, including a unique NDC and a label that fits a 5.25” × 2” area. Estimated annual demand is roughly 472,000 bottles across the three sizes. The solicitation will be posted electronically on or about 01‑Oct‑2026, with a closing date of 15‑Oct‑2026. All questions are to be directed to the Contract Specialist via email.
• Unrestricted federal procurement – open to any qualified pharmaceutical manufacturer or distributor.
• One‑year base period plus up to four one‑year options (potential 5‑year contract).
• Required labeling: unique NDC, VA‑compatible label, specific bottle dimensions.
• Estimated volume: ~392 k × 5 ml, 70 k × 10 ml, 10 k × 15 ml bottles per year.
• Delivery through VA and DoD Pharmaceutical Prime Vendor Programs.
• No paper copies; all documents via SAM.gov.